Evaluation of the neuroprotector effect of an extract of stem bark of Mangifera indica L. (Vimang®) in patient with Spinocerebellar Hereditary Ataxia Type 2 |
Evaluation of the safety and immunogenicity of the vaccine candidate "ABDALA" in children and adolescents |
Evaluation of the synergistic effect of sequential administration of two immunostimulant products: Immuno-1 and Immuno-2 for the stimulation of the immune response in older adults. Exploratory study |
Evidence of the clinical efficacy of VALERGEN-BT vaccine in asthmatics |
Evidence of the clinical efficacy of VALERGEN-DP vaccine in asthmatics |
Evidence of the clinical efficacy of VALERGEN-DS vaccine in asthmatics. |
Expanded Clinical Use of Nasalferon in COVID-19 |
Exploratory study of BMT EV to stimulate immune response in patients with CKD-5 on iterated hemodialysis |
Exploratory study to evaluate the effect and safety of CIGB 500 in seriously ill patients with shock |
Extract of Mangifera indica L. (Vimang®)- Third age- Phase II. |
Extract of Mangifera indica L. (Vimang®)-Ischemic Stroke |
FarmaPEG-I |
FASECU I |
Feasibility and Effectiveness - MAP Online Program - Emerging Adults - Phase II |
Gallbladder retractor and Knot pusher with simultaneous coaxial traction : new laparoscopic instruments. |
Gamma IFN in Idiopathic Pulmonary Fibrosis. |
Gastricel-I |
Glizigen® and Oncoxin®-Viusid® in cervical intraepithelial lesions of adult women. Phase II |
GrUVen-I Study |
h-R3 MaB and radiotherapy in pediatric patients with intrinsic diffuse astrocytomas of brain stem, phase II. |